InvestorsHub Logo
icon url

Evil Rabbit

08/16/20 11:51 AM

#106609 RE: DonDonDonDon #106578

Back when this was “just” a cancer and HIV stock, $1 was an absurdly low valuation.

So your perception of Cytodyn’s value is askew. It was worth much more before COVID came along, but the problem was and continues to be awareness.
icon url

Scooter McCabe

08/16/20 3:37 PM

#106675 RE: DonDonDonDon #106578

What are you talking about?

Leronlimab is only available as apart of ongoing trials. It's not available to the public. So doctors can't promote it as an option.

Myth Busted.